Caseware UK (AP4) 2024.0.164 2024.0.164 22024-01-01truefalseNo description of principal activity2The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 12374929 2024-01-01 2024-12-31 12374929 2023-01-01 2023-12-31 12374929 2024-12-31 12374929 2023-12-31 12374929 c:Director1 2024-01-01 2024-12-31 12374929 d:CurrentFinancialInstruments 2024-12-31 12374929 d:CurrentFinancialInstruments 2023-12-31 12374929 c:Micro-entities 2024-01-01 2024-12-31 12374929 c:AuditExempt-NoAccountantsReport 2024-01-01 2024-12-31 12374929 c:FullAccounts 2024-01-01 2024-12-31 12374929 c:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 12374929 e:PoundSterling 2024-01-01 2024-12-31 iso4217:GBP xbrli:pure


















Neuromodulation Specialists Limited























Unaudited

Financial statements



For the year ended 31 December 2024



Registered number: 12374929

 
Neuromodulation Specialists Limited - Registered number: 12374929

Statement of financial position
As at 31 December 2024

2024
2024
2023
2023
£
£
£
£

  

Fixed assets
  
12,620
9,343

Current assets
  
-
7,010

Creditors: amounts falling due within one year
  
(579,787)
(386,871)

Net current liabilities
  
 
 
(579,787)
 
 
(379,861)

Total assets less current liabilities
  
(567,167)
(370,518)

  

Net liabilities
  
(567,167)
(370,518)


  

Capital and reserves
  
(567,167)
(370,518)


Notes


General information

The company is registered in England and Wales and its registered number is 12374929. The company is a private
company limited by shares. Its registered office is C/O Buzzacott LLP, 130 Wood Street, London, EC2V 6DL.


Average number of employees

The average monthly number of employees during the year was Nil (2023: Nil).


Directors' confirmations

The directors consider that the company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

Page 1

 
Neuromodulation Specialists Limited - Registered number: 12374929

Statement of financial position (continued)
As at 31 December 2024

These financial statements have been prepared in accordance with the provisions applicable to entities subject to the micro-entities' regime.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




Dr T L Yearwood
Director

Date: 25 September 2025

Page 2